Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 33 results found. Search for [ anti-AIDS drugs ]

Results 1 to 21 of 33
E Kumar Sharma
New Delhi, July 18, 2018
Those within the pharma industry see a couple of messages coming across from the movie.


Joe C Mathew
New Delhi, December 11, 2017
India is importing less pharmaceutical raw materials from China, but the Chinese challenge is far from over.


By Joe C. Mathew
Delhi, March 20, 2017
In spite of favourable court verdicts, top pharmaceutical companies are losing enthusiasm for fixed dose combination medicines.


PB Jayakumar
December 30, 2015
Year 2015 should be regarded as a good year for patients worldwide as the USFDA has given approvals for 45 New Molecular Entity and New Therapeutic Biological Products.


E Kumar Sharma
May 27, 2015
Mylan is strongly resisting an unsolicited $40 billion bid by Israel-based Teva to acquire Mylan. But on the other hand, it is also pursuing its own $32.7 billion bid to acquire Ireland-based maker of cough and cold remedies.


E Kumar Sharma
November 21, 2014
API manufacturer Laurus Labs believes in excelling in its chosen segments, not in following trends.


E Kumar Sharma
October 31, 2014
Speaking to Business Today, Cipla Chairman YK Hamied says he is increasingly getting convinced that Ebola is an offshoot of HIV.


E. Kumar Sharma
September 18, 2014
Not all Indian bulk drug makers are reeling before the Chinese onslaught. Some have honed their processes to become world leaders in niche areas.


E. Kumar Sharma
June 19, 2014
Experts says consolidation, which may well have major implications, is inevitable in Indian pharma. Market watchers say that among the major Indian pharma companies the two most prized pickings would be Dr. Reddy's Laboratories and Cipla Ltd.


E. Kumar Sharma
May 31, 2014
In the seven years since, Mylan Inc has invested around $3 billion on acquisitions in India. It now regards India not just as a global sourcing hub, but also as a market.


Mail Today Bureau
New Delhi, May 5, 2014
Cipla chairman Yusuf Hamied, who has long battled global pharmaceutical majors to ensure that developing countries have access to life-saving drugs, has said that a pricecontrol mechanism is required in India for essential medicines sold under a monopoly.


IANS
New Delhi, May 3, 2014
\"India is not just contributing to the arena of medicines but also playing a humanitarian role by manufacturing medicines and supplying them at a low cost across the world,\" Hamied said.


E Kumar Sharma
April 29, 2014
Cipla, whose chairman Yusuf Khwaja Hamied, jolted the global pharma industry in 2001 with his offer to sell anti-AIDS drugs at less than 4 per cent of the price charged by international drugmakers, in January this year got a notice for overcharging for some medicines in India.


IANS
New Delhi, March 10, 2014
\"87 developing nations, their entire health care system is supported by Indian medicines, and we're committed to ensure that even the new generation of life-saving drugs, the Indian pharmaceutical industry will make, are available to our people and people of developing countries,\" Commerce Minister Anand Sharma said.


E. Kumar Sharma
February 12, 2014
Dr Peter Mugyenyi, author of Genocide by Denial: How Profiteering from HIV/AIDS Killed Millions (2008) has joined the board of Cipla as an independent director.


Chaitanya Kalbag
May 8, 2013
It turns out that India is crawling with thousands of chit funds and other dubious deposit-taking rackets, and cheat shops emerge from the shadows in examples like the 130 Kerala chit funds that set up office in one building in the industrial town of Faridabad in Haryana.


E. Kumar Sharma
May 9, 2013
Y.K. Hamied steps down as managing director of Cipla in February. His decision to function as non-executive chairman from April 1 and other management changes are significant. The move is part of a major transformation aimed at propelling the company into a new orbit.


E Kumar Sharma
January 2, 2013
The US Food and Drug Administration (FDA) has approved an anti-diarrhoea drug, co-developed by Glenmark Pharmaceuticals and US-based Salix Pharmaceuticals Inc.


E. Kumar Sharma
November 23, 2012
The deal, when concluded, will give Cipla more access to the region and a direct, customer-facing presence in a key export market. Medpro would be the biggest international acquisition by the company, though not the first - officials confirm that its already has stakes in some foreign companies.


www.businesstoday.in
June 7, 2012
Starring: J.S. Sarma, Rahul Khullar, Dev Amritesh, Y.K. Hamied, Hiroyuki Suzuki, Pallavi Jha


PAGES 1 OF 2  12